[go: up one dir, main page]

TW200510447A - Novel fusidic acid derivatives - Google Patents

Novel fusidic acid derivatives

Info

Publication number
TW200510447A
TW200510447A TW093121380A TW93121380A TW200510447A TW 200510447 A TW200510447 A TW 200510447A TW 093121380 A TW093121380 A TW 093121380A TW 93121380 A TW93121380 A TW 93121380A TW 200510447 A TW200510447 A TW 200510447A
Authority
TW
Taiwan
Prior art keywords
acid derivatives
fusidic acid
novel
novel fusidic
infections
Prior art date
Application number
TW093121380A
Other languages
English (en)
Inventor
Tore Duvold
Laetitia Bouerat
Poul Rodbroe Rasmussen
Claus Aage Svensgaard Bretting
Jacob Thorhauge
Original Assignee
Leo Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharma As filed Critical Leo Pharma As
Publication of TW200510447A publication Critical patent/TW200510447A/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J13/00Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J13/00Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/002Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 13 (17)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J17/00Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J51/00Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J53/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C07J9/005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
TW093121380A 2003-07-16 2004-07-16 Novel fusidic acid derivatives TW200510447A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200301080 2003-07-16
US48760903P 2003-07-17 2003-07-17
DKPA200301486 2003-10-09

Publications (1)

Publication Number Publication Date
TW200510447A true TW200510447A (en) 2005-03-16

Family

ID=34084106

Family Applications (1)

Application Number Title Priority Date Filing Date
TW093121380A TW200510447A (en) 2003-07-16 2004-07-16 Novel fusidic acid derivatives

Country Status (6)

Country Link
KR (1) KR20060091290A (zh)
IL (1) IL172699A0 (zh)
IS (1) IS8301A (zh)
MX (1) MXPA06000423A (zh)
NO (1) NO20060614L (zh)
TW (1) TW200510447A (zh)

Also Published As

Publication number Publication date
IL172699A0 (en) 2006-04-10
IS8301A (is) 2006-02-14
KR20060091290A (ko) 2006-08-18
MXPA06000423A (es) 2006-04-05
NO20060614L (no) 2006-02-08

Similar Documents

Publication Publication Date Title
AU2003220553A1 (en) Combination therapy for the treatment of conditions with pathogenic inflammatory components
UA84025C2 (en) Normal;heading 1;heading 2;2-(QUINOXALIN-5-YLSULFONYLAMINO)-BENZAMIDE COMPOUNDS AS CCK2 MODULATORS
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
TW200505881A (en) Tri(cyclo) substituted amide compounds
MY149957A (en) Heterocyclic inhibitors of mek and methods of use thereof
UA85559C2 (en) Aminobenzophenone compounds
IL172346A0 (en) Treatment of t cell mediated diseases by inhibition of fgfr3
AU2003213768A1 (en) Use of benzimidazole analogs in the treatment of cell proliferation
GB0209891D0 (en) Novel compounds
NO20053042L (no) Anvendelse av spongosin (2-metoksyadenosin) for behandling av smerte, saerlig hyperalgesi.
AU2003286728A1 (en) Compounds for the treatment of metabolic disorders
GB0416508D0 (en) Therapeutic agents
AU2003258145A1 (en) Substituted phenylindoles for the treatment of hiv
TW200630367A (en) Substituted adenines and the uses thereof
CO5660287A2 (es) Derivados de tetrahidrocarbazol y su uso farmaceutico
IL163951A (en) Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
IL165562A0 (en) Prodrugs of imidazole derivatives for use as proton pump inhibitors in the treatment of e.g. peptic ulcers
AU2003903242A0 (en) Process for the treatment of wood
GB0326633D0 (en) Therapeutic agents
IL162818A0 (en) Combination therapy for the treatment of bacterialinfections
GEP20094699B (en) THERAPIES FOR CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY USING ß-INTERFERON
MY140194A (en) Novel fusidic acid derivatives
MX2007010484A (es) Moleculas y metodos para usarlas para tratar enfermedades asociadas con mcp-1/ccr2.
SG144942A1 (en) Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
IL177169A0 (en) Use of n- (2-aryl-propionyl)-sulfonamides for the treatment of spinal cord injury